You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 1 Articles
Popular Type 1 Articles
Highly Recommended Type 1 Articles
Send a link to this page to your friends and colleagues.
University of California researchers report that they have found a new class of drugs that could lead to a pain relief treatment for people who have diabetic neuropathy. The drugs, which were successfully tested on lab animals, are anti-inflammatory compounds that inhibit the action of an enzyme called soluble epoxide hydrolase. The enzyme is key to the transmission of pain sensations. Previous research has shown that inhibiting soluble epoxide hydrolase also lowers blood pressure and protects against kidney damage.
Researchers at the University of California, Davis, led by Bora Inceoglu, also report that the compounds produce no apparent side effects.
An estimated half of all advanced diabetes patients suffer from neuropathy, a painful condition caused by damage to the nerves from diabetic inflammation. There are currently no highly effective drugs or other therapies for dealing with the condition. "Our data indicate that this drug candidate is more effective on neuropathic pain caused by diabetes than any of the prescription drugs now on the market," said Bruce Hammock, the study's co-author. However, it will be awhile before the new drug is available. FDA protocols for testing and then approving a drug for market can take up to 10 years, and many drugs fail the process.
The study was published in the Proceedings of the National Academy of Sciences.
0 comments - Jul 7, 2012
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.